We are live on ! Find out more
RJA

Raymond James & Associates Portfolio holdings

AUM $164B
1-Year Est. Return 33.91%
This Fund
S&P 500
This Quarter Est. Return
+7.04%
1 Year Est. Return
+33.91%
3 Year Est. Return
+39.99%
5 Year Est. Return
+107.66%
10 Year Est. Return
+436.07%
AUM
$110B
AUM Growth
+$10.8B
Cap. Flow
+$4.52B
Cap. Flow %
4.11%
Top 10 Hldgs %
23.63%
Holding
4,320
New
332
Increased
2,194
Reduced
1,423
Closed
241

Sector Composition

Rank Sector Weight
1 Technology 14.49%
2 Financials 8.91%
3 Healthcare 8.14%
4 Industrials 6.57%
5 Consumer Discretionary 6.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FAB icon
3001
First Trust Multi Cap Value AlphaDEX Fund
FAB
$176M
$561K ﹤0.01%
7,899
-204
-3% -$14.7K
XPH icon
3002
State Street SPDR S&P Pharmaceuticals ETF
XPH
$509M
$561K ﹤0.01%
10,828
-197
-2% -$9.89K
DIV icon
3003
Global X SuperDividend US ETF
DIV
$773M
$559K ﹤0.01%
27,979
+3,957
+16% +$79K
JPT
3004
DELISTED
Nuveen Preferred and Income Fund
JPT
$559K ﹤0.01%
22,370
+2,508
+13% +$62K
SHYD icon
3005
VanEck Short High Yield Muni ETF
SHYD
$455M
$556K ﹤0.01%
21,862
+5,416
+33% +$137K
TIXT
3006
DELISTED
TELUS International
TIXT
$552K ﹤0.01%
17,762
-1,526
-8% -$45.8K
VC icon
3007
Visteon
VC
$2.83B
$552K ﹤0.01%
4,567
+2,444
+115% +$294K
BFZ
3008
DELISTED
BlackRock CA Municipal Income Trust
BFZ
$551K ﹤0.01%
36,752
-4,920
-12% -$72.4K
MUNI icon
3009
PIMCO Intermediate Municipal Bond Active Exchange-Traded Fund
MUNI
$3.12B
$550K ﹤0.01%
9,682
-1,815
-16% -$103K
PBE icon
3010
Invesco Biotechnology & Genome ETF
PBE
$358M
$550K ﹤0.01%
7,108
IBTD
3011
DELISTED
iShares iBonds Dec 2023 Term Treasury ETF
IBTD
$550K ﹤0.01%
+21,473
New +$551K
FINV
3012
FinVolution Group
FINV
$1.05B
$549K ﹤0.01%
57,616
+21,040
+58% +$159K
JQUA icon
3013
JPMorgan US Quality Factor ETF
JQUA
$8.56B
$547K ﹤0.01%
+13,368
New +$530K
BNY
3014
DELISTED
BlackRock New York Municipal Income Trust
BNY
$546K ﹤0.01%
36,164
+19,099
+112% +$284K
PUBM icon
3015
PubMatic
PUBM
$804M
$545K ﹤0.01%
13,939
+5,651
+68% +$235K
PVH icon
3016
PVH
PVH
$3.91B
$544K ﹤0.01%
5,053
+1,063
+27% +$117K
CAF
3017
Morgan Stanley China A Share Fund
CAF
$326M
$542K ﹤0.01%
23,686
+3,040
+15% +$69.7K
CSW
3018
CSW Industrials
CSW
$5.72B
$542K ﹤0.01%
4,575
+2,595
+131% +$331K
CELL
3019
DELISTED
PhenomeX Inc. Common Stock
CELL
$542K ﹤0.01%
12,103
+4,490
+59% +$208K
STMP
3020
DELISTED
Stamps.com, Inc.
STMP
$542K ﹤0.01%
+2,705
New +$530K
SITM icon
3021
SiTime
SITM
$20.1B
$541K ﹤0.01%
4,277
-1,293
-23% -$132K
QTRX icon
3022
Quanterix
QTRX
$124M
$540K ﹤0.01%
9,201
+927
+11% +$53.8K
JDIV
3023
DELISTED
JPMorgan U.S. Dividend ETF
JDIV
$540K ﹤0.01%
16,583
+9,839
+146% +$320K
FT
3024
Franklin Universal Trust
FT
$198M
$539K ﹤0.01%
65,152
-2,887
-4% -$22.8K
PSCD icon
3025
Invesco S&P SmallCap Consumer Discretionary ETF
PSCD
$24M
$539K ﹤0.01%
4,594
+375
+9% +$43.5K

Similar funds

Raymond James & Associates's Q2 2021 Portfolio in Review

As of Q2 2021, Raymond James & Associates held 4,320 positions worth $110B, up 11% from $99.1B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Raymond James & Associates deployed $4.52B of net new capital in Q2 2021, opening 332 new positions and adding to 2,194 existing holdings. Its largest new stake was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.

By sector, the portfolio is most concentrated in Technology at 14% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was Amgen, an estimated $175M trimmed.

  • Raymond James & Associates's largest Q2 2021 buy was Just Eat Takeaway.com N.V. American Depositary Shares: 583,879 shares worth $10.7M.
  • Raymond James & Associates added most to Vanguard S&P 500 ETF in Q2 2021, an estimated $290M increase.
  • Raymond James & Associates's biggest Q2 2021 reduction was Amgen, cutting an estimated $175M.
  • Raymond James & Associates fully exited FLIR Systems, Inc. (DE) Common Stock in Q2 2021, selling an estimated $19.1M.
  • Raymond James & Associates's ten largest holdings make up 24% of its $110B portfolio in Q2 2021.
  • Raymond James & Associates opened 332 new positions and closed 241 in Q2 2021.
  • Raymond James & Associates's portfolio value rose 11% quarter-over-quarter to $110B.

Based on Raymond James & Associates's 13F filing for Q2 2021, filed 11 Aug 2021.